Maternal group B Streptococcus decreases infant length and alters the early-life microbiome: a prospective cohort study
2024

Maternal Group B Streptococcus and Infant Growth

Sample size: 453 publication 10 minutes Evidence: moderate

Author Information

Author(s): S. Li, Qijun Liang, Qing Wei, Fang Zhencheng, Yuan Chunlei, Pan Shilei, Xie Hairui, Li Xiaocong, Chen Muxuan, He Yan, Zhou Hongwei, Wang Qian

Primary Institution: Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Hypothesis

Does maternal vaginal Group B Streptococcus (GBS) during pregnancy affect early infant growth and microbiome?

Conclusion

Maternal GBS exposure is linked to reduced infant length growth, potentially mediated by changes in gut microbiota and metabolites.

Supporting Evidence

  • GBS-exposed infants had lower length-for-age z-scores than GBS-unexposed infants.
  • Altered gut microbiota in GBS-exposed infants correlated with growth.
  • Maternal GBS colonization was linked to changes in infant microbiota and metabolites.

Takeaway

Moms with a certain bacteria called GBS can make their babies grow shorter in length, and this might be because of changes in the baby’s tummy bacteria.

Methodology

The study recruited 453 pregnant women, analyzed infant growth and microbiota using 16S rDNA sequencing and metabolomics.

Potential Biases

Potential confounding factors included maternal age and gestational age.

Limitations

The study was limited to southern China and had a short follow-up period; broader studies are needed for validation.

Participant Demographics

Pregnant women aged 18-40 years, with singleton pregnancies, from southern China.

Statistical Information

P-Value

0.00037

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1080/07853890.2024.2442070

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication